Abstract:Wuping Bao, 1, * Xue Zhang, 1, * Yubiao Jin, 2, * Huijuan Hao, 1 Fu Yang, 3 Dongning Yin, 1 Xi Chen, 3 Yishu Xue, 1 Lei Han, 1 Min Zhang 1 1 Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 3 Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China *These authors contributed equally to this work Correspondence: Min Zhang Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100, Haining Road, Shanghai, 200080, People's Republic of China Email Background: Whether COVID-19 comorbidities and risk factors such as old age, male gender, smoking, obesity, eosinophils and blood types have direct contact with expression of ACE2 and pro-inflammation cytokines in human lung tissues were still unclear. Patients and Methods: Sixty-four patients with normal FEV 1 and FEV 1 /FVC underwent thoracotomy for pulmonary nodules were included. Blinded histological assessments were performed by two pathologists. Clinical features and results of the immunohistochemical staining of ACE2 were collected and analyzed. Results: ACE2 expressed in alveolar macrophages (most obvious), alveolar epithelia and vascular endothelia, but not in small-airway epithelia. ACE2 expressions are positively related to age ( r =0.26, P =0.040), weight ( r =0.43, P < 0.001), as well as BMI ( r = 0.38, P =0.002), and male patients show higher expressions of ACE2 in lungs ( P < 0.05). ACE2 expressions are negatively related to peripheral eosinophils ( r = − 0.30, P =0.017). There was no correlation between ABO blood types and ACE2 expression in normal lung tissues ( P > 0.05). IL-13 and IL-6R expression in lung tissue increased with age ( r =0.26, P < 0.05, for both). Conclusion: Our pathological evidences showed that the alveolar epithelia, vascular endothelia, and alveolar macrophages are susceptible in human lungs for SARS-CoV-2 infection. The risk factors such as high body weight/BMI, old age, male gender, and eosinopenia may be related to ACE2 expression in human lungs, and associated with more chance to develop the severe cases. IL-6R expression in lung tissue also increased with age. Therefore, weight control and smoking cessation are essential to reduce the susceptibility of SARS-CoV-2 infection, especially in obesity, old or male patients. Peripheral eosinophils monitor is also quite necessary to detect severe tendency in COVID-19 patients. Keywords: ACE2, risk factor, BMI, age, sex, eosinophils A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leading to the coronavirus disease 2019 (COVID-19) was first identified in December 2019 and rapidly swept across the globe. More than 85 million people have been confirmed and more than 1.8 million people dead worldwide (as of December 2020). 1 It has been estimated that 1 in 5–10 adults with positive COVID-19 requiring hospital admission, 2 with rates of admission to the intensive care unit (ICU) in China, Europe, and the United States ranging from 5% to 32%. 3–11 The severity of COVID-19 illness poses a great strain to medical resources and a great burden to social economy. Therefore, early identification of risk factors of COVID-19 is essential to protect susceptible population, and might help to provide proper prevention, close observation and treatment. Many potential COVID-19 comorbidities and risk factors such as coronary artery disease, hypertension, diabetes, COPD, asthma, autoimmune disease, old age, male gender, smoking, and obesity have been demonstrated to affect the process and severity of COVID-19 illness. 12 , 13 And the effect of some risk factors, such as eosinophils and blood types in COVID-19 is still controversial. SARS-CoV-2 attaches and enters host cells first via a transmembrane receptor angiotensin-converting enzyme 2 (ACE2). ACE2 is widely distributed in various human tissues, and in the respiratory system, it is mainly expressed in -Abstract Truncated-

ACE2 and COVID-19 Susceptibility and Severity

Investigation of the Genetic Variation in ACE2 on the Structural Recognition by the Novel Coronavirus (Sars-Cov-2)

Single-cell RNA expression profiling shows that ACE2, the putative receptor of COVID-2019, has significant expression in nasal and mouth tissue, and is co-expressed with TMPRSS2 and not co-expressed with SLC6A19 in the tissues

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract

Individual Variation of the SARS‐CoV‐2 Receptor ACE2 Gene Expression and Regulation

Impact of ACE2 on the susceptibility and vulnerability to COVID-19

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

Interaction network of SARS-CoV-2 with host receptome through spike protein

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

ACE2 and TMPRSS2 distribution in the respiratory tract of different animal species and its correlation with SARS-CoV-2 tissue tropism

Susceptibilities of human ACE2 genetic variants in coronavirus infection

Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis

Lineage-specific Positive Selection on ACE2 Contributes to the Genetic Susceptibility of COVID-19.

An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection

The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2

Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV1 and FEV1/FVC

ACE2-Independent Alternative Receptors for SARS-CoV-2

Manipulation of ACE2 expression in COVID-19